Cholinergic abnormalities in Alzheimer's disease: identification of novel therapeutic targets

  • Small, David (Primary Chief Investigator (PCI))
  • Aguilar, Mibel (Chief Investigator (CI))
  • Collins (Chebib), Mary (Chief Investigator (CI))
  • Perlmutter, Patrick (Chief Investigator (CI))
  • Hill, Andrew (Partner Investigator (PI))
  • Livett, Bruce (Partner Investigator (PI))

Project: Research

Project Details

StatusFinished
Effective start/end date1/01/0431/12/06

Funding

  • National Health and Medical Research Council (NHMRC) (Australia): AUD471,000.00